Ignite Creation Date:
2025-12-25 @ 2:47 AM
Ignite Modification Date:
2026-05-14 @ 5:18 PM
Study NCT ID:
NCT02396433
Status:
WITHDRAWN
Last Update Posted:
2015-08-25
First Post:
2015-02-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Combination of Carboplatin, Eribulin Mesylate, and E7449 in BRCA-Related Cancers
Sponsor:
The University of Texas Health Science Center at San Antonio
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CTMS# 14-2024
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None